Viwit

Viwit

You are here: HomeProductsVildagliptin

Contact us

  • Company Name: Viwit
  • Country/region: China
  • Contact Person: Mr.Keene Wei
  • Tel: 86-21-37775618
  • Email:

Vildagliptin

  • CAS No:274901-16-5 Vildagliptin
    Molecular Structure

    Detailed Description

    Vildagliptin (previously identified as LAF237, trade names Zomelis, Galvus, cas 274901-16-5) is an oral anti-hyperglycemic agent (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin (cas 274901-16-5) inhibits the inactivation of GLP-1 and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas.Vildagliptin (cas 274901-16-5) has been shown to reduce hyperglycemia in type 2 diabetes mellitus.